Real-World Implementation of Simulation-Free Radiation Therapy (SFRT-1000): A Propensity Score-Matched Analysis of 1000 Consecutive Palliative Courses Delivered in Routine Care.
Saved in:
| Title: | Real-World Implementation of Simulation-Free Radiation Therapy (SFRT-1000): A Propensity Score-Matched Analysis of 1000 Consecutive Palliative Courses Delivered in Routine Care. |
|---|---|
| Authors: | Schuler, Thilo1,2 (AUTHOR) thilo.schuler@health.nsw.gov.au, Roderick, Stephanie1 (AUTHOR), Wong, Shelley1 (AUTHOR), Kejda, Alannah1 (AUTHOR), Grimberg, Kylie1 (AUTHOR), Lowe, Toby1 (AUTHOR), Kipritidis, John1,3 (AUTHOR), Back, Michael1,4 (AUTHOR), Bergamin, Sarah1,4 (AUTHOR), Carroll, Susan1,4 (AUTHOR), Hruby, George1,4 (AUTHOR), Jayamanne, Dasantha1,4 (AUTHOR), Kneebone, Andrew1,4 (AUTHOR), Lamoury, Gillian1,4 (AUTHOR), Morgia, Marita1 (AUTHOR), Stevens, Mark1 (AUTHOR), Brown, Chris5 (AUTHOR), Gallego, Blanca6 (AUTHOR), Porter, Brian1 (AUTHOR), Booth, Jeremy1,3 (AUTHOR) |
| Source: | International Journal of Radiation Oncology, Biology, Physics. Mar2025, Vol. 121 Issue 3, p585-595. 11p. |
| Subjects: | Pain management, Stereotaxic techniques, Radiotherapy, Treatment duration, Treatment effectiveness |
| Abstract: | The feasibility of simulation-free radiation therapy (SFRT) has been demonstrated but information regarding its routine care impact and scalability is lacking. In this single-institution, retrospective cohort study, all patients receiving palliative radiation therapy at an Australian tertiary cancer center were eligible for consideration of SFRT unless mask immobilization, a stereotactic technique, or a definitive dose was indicated. Coprimary endpoints were SFRT utilization, impact on consultation-to-RT time, and on-couch treatment duration. Timing metrics were compared with a contemporary local cohort that received simulation-based palliative radiation therapy using unadjusted Wilcoxon rank-sum tests and a propensity score-matched regression. Electronic patient-reported outcomes captured 2-week toxicity and pain response. Between April 2018 and February 2024, 2849 palliative radiation courses were delivered, of which 1904 were eligible. Of the 1904 courses, 1000 (52.5% SFRT utilization) received SFRT, including 668 using intensity-modulated radiation therapy/volumetric-modulated arc therapy. A total of 788 individual patients received SFRT and the median age was 71 years (IQR, 61-80) with 59% being male and 42% being Eastern Collaborative Oncology Group 2-4. SFRT utilization increased from 41% to 54% between years 2018-2019 and 2022-2024. SFRT reduced median consultation-to-RT time from 7.0 to 5.1 days (P <.0001) corresponding to an adjusted average treatment effect in the treated of −2.1 days (95% CI, −2.8 to −1.3). SFRT increased median on-couch treatment duration from 17.8 to 20.5 minutes (P <.0001; adjusted average treatment effect in the treated 2.6 minutes, 95% CI, 1.3-3.9). Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events grade 3 acute toxicity was 9% and at 4 weeks after RT, patients with moderate/severe pain at baseline (≥5/10) had a mean pain reduction of 3.5 points (7.1-3.6; P <.0001). Using widely available technologies, the SFRT-1000 cohort demonstrates routine care scalability with patient-centered and workflow benefits. SFRT is an attractive new paradigm implementable in most settings following adaptation to local requirements. Thus, SFRT opens new avenues to potentially improve access to palliative RT, which remains a global area of need. [ABSTRACT FROM AUTHOR] |
| Copyright of International Journal of Radiation Oncology, Biology, Physics is the property of Pergamon Press - An Imprint of Elsevier Science and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Engineering Source |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: egs DbLabel: Engineering Source An: 182500388 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Real-World Implementation of Simulation-Free Radiation Therapy (SFRT-1000): A Propensity Score-Matched Analysis of 1000 Consecutive Palliative Courses Delivered in Routine Care. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Schuler%2C+Thilo%22">Schuler, Thilo</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> thilo.schuler@health.nsw.gov.au</i><br /><searchLink fieldCode="AR" term="%22Roderick%2C+Stephanie%22">Roderick, Stephanie</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wong%2C+Shelley%22">Wong, Shelley</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kejda%2C+Alannah%22">Kejda, Alannah</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Grimberg%2C+Kylie%22">Grimberg, Kylie</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lowe%2C+Toby%22">Lowe, Toby</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kipritidis%2C+John%22">Kipritidis, John</searchLink><relatesTo>1,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Back%2C+Michael%22">Back, Michael</searchLink><relatesTo>1,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bergamin%2C+Sarah%22">Bergamin, Sarah</searchLink><relatesTo>1,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Carroll%2C+Susan%22">Carroll, Susan</searchLink><relatesTo>1,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hruby%2C+George%22">Hruby, George</searchLink><relatesTo>1,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jayamanne%2C+Dasantha%22">Jayamanne, Dasantha</searchLink><relatesTo>1,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kneebone%2C+Andrew%22">Kneebone, Andrew</searchLink><relatesTo>1,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lamoury%2C+Gillian%22">Lamoury, Gillian</searchLink><relatesTo>1,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Morgia%2C+Marita%22">Morgia, Marita</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Stevens%2C+Mark%22">Stevens, Mark</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Brown%2C+Chris%22">Brown, Chris</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gallego%2C+Blanca%22">Gallego, Blanca</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Porter%2C+Brian%22">Porter, Brian</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Booth%2C+Jeremy%22">Booth, Jeremy</searchLink><relatesTo>1,3</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22International+Journal+of+Radiation+Oncology%2C+Biology%2C+Physics%22">International Journal of Radiation Oncology, Biology, Physics</searchLink>. Mar2025, Vol. 121 Issue 3, p585-595. 11p. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22Pain+management%22">Pain management</searchLink><br /><searchLink fieldCode="DE" term="%22Stereotaxic+techniques%22">Stereotaxic techniques</searchLink><br /><searchLink fieldCode="DE" term="%22Radiotherapy%22">Radiotherapy</searchLink><br /><searchLink fieldCode="DE" term="%22Treatment+duration%22">Treatment duration</searchLink><br /><searchLink fieldCode="DE" term="%22Treatment+effectiveness%22">Treatment effectiveness</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: The feasibility of simulation-free radiation therapy (SFRT) has been demonstrated but information regarding its routine care impact and scalability is lacking. In this single-institution, retrospective cohort study, all patients receiving palliative radiation therapy at an Australian tertiary cancer center were eligible for consideration of SFRT unless mask immobilization, a stereotactic technique, or a definitive dose was indicated. Coprimary endpoints were SFRT utilization, impact on consultation-to-RT time, and on-couch treatment duration. Timing metrics were compared with a contemporary local cohort that received simulation-based palliative radiation therapy using unadjusted Wilcoxon rank-sum tests and a propensity score-matched regression. Electronic patient-reported outcomes captured 2-week toxicity and pain response. Between April 2018 and February 2024, 2849 palliative radiation courses were delivered, of which 1904 were eligible. Of the 1904 courses, 1000 (52.5% SFRT utilization) received SFRT, including 668 using intensity-modulated radiation therapy/volumetric-modulated arc therapy. A total of 788 individual patients received SFRT and the median age was 71 years (IQR, 61-80) with 59% being male and 42% being Eastern Collaborative Oncology Group 2-4. SFRT utilization increased from 41% to 54% between years 2018-2019 and 2022-2024. SFRT reduced median consultation-to-RT time from 7.0 to 5.1 days (P <.0001) corresponding to an adjusted average treatment effect in the treated of −2.1 days (95% CI, −2.8 to −1.3). SFRT increased median on-couch treatment duration from 17.8 to 20.5 minutes (P <.0001; adjusted average treatment effect in the treated 2.6 minutes, 95% CI, 1.3-3.9). Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events grade 3 acute toxicity was 9% and at 4 weeks after RT, patients with moderate/severe pain at baseline (≥5/10) had a mean pain reduction of 3.5 points (7.1-3.6; P <.0001). Using widely available technologies, the SFRT-1000 cohort demonstrates routine care scalability with patient-centered and workflow benefits. SFRT is an attractive new paradigm implementable in most settings following adaptation to local requirements. Thus, SFRT opens new avenues to potentially improve access to palliative RT, which remains a global area of need. [ABSTRACT FROM AUTHOR] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of International Journal of Radiation Oncology, Biology, Physics is the property of Pergamon Press - An Imprint of Elsevier Science and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=egs&AN=182500388 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.ijrobp.2024.09.041 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 11 StartPage: 585 Subjects: – SubjectFull: Pain management Type: general – SubjectFull: Stereotaxic techniques Type: general – SubjectFull: Radiotherapy Type: general – SubjectFull: Treatment duration Type: general – SubjectFull: Treatment effectiveness Type: general Titles: – TitleFull: Real-World Implementation of Simulation-Free Radiation Therapy (SFRT-1000): A Propensity Score-Matched Analysis of 1000 Consecutive Palliative Courses Delivered in Routine Care. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Schuler, Thilo – PersonEntity: Name: NameFull: Roderick, Stephanie – PersonEntity: Name: NameFull: Wong, Shelley – PersonEntity: Name: NameFull: Kejda, Alannah – PersonEntity: Name: NameFull: Grimberg, Kylie – PersonEntity: Name: NameFull: Lowe, Toby – PersonEntity: Name: NameFull: Kipritidis, John – PersonEntity: Name: NameFull: Back, Michael – PersonEntity: Name: NameFull: Bergamin, Sarah – PersonEntity: Name: NameFull: Carroll, Susan – PersonEntity: Name: NameFull: Hruby, George – PersonEntity: Name: NameFull: Jayamanne, Dasantha – PersonEntity: Name: NameFull: Kneebone, Andrew – PersonEntity: Name: NameFull: Lamoury, Gillian – PersonEntity: Name: NameFull: Morgia, Marita – PersonEntity: Name: NameFull: Stevens, Mark – PersonEntity: Name: NameFull: Brown, Chris – PersonEntity: Name: NameFull: Gallego, Blanca – PersonEntity: Name: NameFull: Porter, Brian – PersonEntity: Name: NameFull: Booth, Jeremy IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: Mar2025 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 03603016 Numbering: – Type: volume Value: 121 – Type: issue Value: 3 Titles: – TitleFull: International Journal of Radiation Oncology, Biology, Physics Type: main |
| ResultId | 1 |